<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01852903</url>
  </required_header>
  <id_info>
    <org_study_id>11CIHE</org_study_id>
    <nct_id>NCT01852903</nct_id>
  </id_info>
  <brief_title>Comparative Bioavailability of Two Forms of Vitamin C</brief_title>
  <official_title>A Randomized, Double-blind, Placebo-controlled Crossover Study Comparing the Bioavailability of Two Forms of Vitamin C in Plasma and Leukocytes Over 24 Hours.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>NBTY, Inc.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>KGK Science Inc.</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
    <collaborator>
      <agency>Moyad, Mark MD MPH</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>NBTY, Inc.</source>
  <brief_summary>
    <textblock>
      The purpose of this study is to compare levels of vitamin C in the blood over the 24 hour&#xD;
      period following a single 1000 mg dose of vitamin C from ascorbic acid, calcium ascorbate and&#xD;
      placebo.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>May 2011</start_date>
  <primary_completion_date type="Actual">July 2011</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>Triple (Participant, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Plasma and leukocyte vitamin C concentration</measure>
    <time_frame>0, 2, 4, 8 and 24 hours</time_frame>
  </primary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Actual">40</enrollment>
  <condition>Bioavailability</condition>
  <arm_group>
    <arm_group_label>calcium ascorbate</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>ascorbic acid</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>calcium ascorbate</intervention_name>
    <arm_group_label>calcium ascorbate</arm_group_label>
    <other_name>vitamin C</other_name>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>ascorbic acid</intervention_name>
    <arm_group_label>ascorbic acid</arm_group_label>
    <other_name>vitamin C</other_name>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>placebo</intervention_name>
    <arm_group_label>placebo</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Healthy as determined by laboratory results and medical history&#xD;
&#xD;
          -  Females not of child bearing potential&#xD;
&#xD;
          -  BMI 18-30 kg/m2&#xD;
&#xD;
          -  Agrees to consume a low vitamin C diet&#xD;
&#xD;
          -  Non-smoker or ex-smoker &gt;1 year&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Pregnant, breastfeeding, or planning to become pregnant during the trial&#xD;
&#xD;
          -  Alcohol &gt;2 drinks per day; alcohol or drug abuse within the past year&#xD;
&#xD;
          -  Cardiac conditions&#xD;
&#xD;
          -  Duodenal ulcer or gastric ulcer, gastritis, hiatus hernia, or gastroesophageal reflux&#xD;
             disease (GERD) within past 3 months&#xD;
&#xD;
          -  History irritable bowel syndrome, malabsorption or significant GI disease&#xD;
&#xD;
          -  History of kidney stones&#xD;
&#xD;
          -  Use of medications known to interact with vitamin C&#xD;
&#xD;
          -  Use of supplements containing vitamin C&#xD;
&#xD;
          -  Use of anticoagulants (warfarin), barbiturates, tetracycline antibiotics,&#xD;
             beta-blockers, cyclosporine, prednisone, tricyclic antidepressants, diuretics and&#xD;
             nitrate medications&#xD;
&#xD;
          -  History of or current diagnosis of cancer&#xD;
&#xD;
          -  Uncontrolled hypertension&#xD;
&#xD;
          -  History of diabetes, renal disease and/or liver disease&#xD;
&#xD;
          -  Unstable psychiatric disorder&#xD;
&#xD;
          -  History of or current immunocompromise&#xD;
&#xD;
          -  History of hemochromatosis or hemoglobinopathies&#xD;
&#xD;
          -  Participation in a clinical research trial &lt;30 days&#xD;
&#xD;
          -  Use of acute medication w/in 72 hours of intervention&#xD;
&#xD;
          -  Unstable medications &lt;90 days&#xD;
&#xD;
          -  Abnormal liver function&#xD;
&#xD;
          -  Serum creatinine &gt; 1.5 x upper limit of normal (ULN)&#xD;
&#xD;
          -  Anemia of any etiology&#xD;
&#xD;
          -  Blood donation w/in the last 2 months&#xD;
&#xD;
          -  Allergy or sensitivity to test articles, foods or beverages provided during the study&#xD;
&#xD;
          -  Cognitive impairment and/or unable to give informed consent&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>60 Years</maximum_age>
  </eligibility>
  <overall_official>
    <last_name>Dale R Wilson, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>KGK Science Inc.</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>KGK Synergize Inc</name>
      <address>
        <city>London</city>
        <state>Ontario</state>
        <zip>N6A 5R8</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Canada</country>
  </location_countries>
  <verification_date>May 2013</verification_date>
  <study_first_submitted>May 9, 2013</study_first_submitted>
  <study_first_submitted_qc>May 9, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">May 14, 2013</study_first_posted>
  <last_update_submitted>May 9, 2013</last_update_submitted>
  <last_update_submitted_qc>May 9, 2013</last_update_submitted_qc>
  <last_update_posted type="Estimate">May 14, 2013</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>vitamin C</keyword>
  <keyword>calcium ascorbate</keyword>
  <keyword>ascorbic acid</keyword>
  <keyword>bioavailability</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Vitamins</mesh_term>
    <mesh_term>Ascorbic Acid</mesh_term>
    <mesh_term>Calcium ascorbate</mesh_term>
    <mesh_term>Calcium</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

